Compare
Teleflex Inc vs Integra Lifesciences Holdings Corp vs Merit Medical Systems Inc vs Penumbra Inc
| Latest fiscal year | Teleflex Inc TFX | Integra Lifesciences Holdings Corp IART | Merit Medical Systems Inc MMSI | Penumbra Inc PEN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.99B | $1.64B | $1.52B | $1.40B |
| Revenue growth (YoY) | +17.2% | +1.5% | +11.8% | +17.5% |
| Gross margin | 56.2% | 50.9% (computed) | 48.7% | 67.1% |
| Operating margin | 5.9% | -30.2% | 12.2% | 13.5% |
| Net margin | -45.4% | -31.6% | 8.5% | 12.7% |
| Net income | -$905.64M | -$516.47M | $128.49M | $177.69M |
| EPS (Diluted) | -$20.25 | -$6.74 | $2.13 | $4.52 |
| Operating cash flow | $96.68M | $50.38M | $297.37M | $238.66M |
| Free cash flow | $1.45M | -$31.05M | $215.66M | $174.93M |
| Cash & equivalents | $378.56M | $235.05M | $446.40M | $186.90M |
| Total assets | $6.95B | $3.60B | $2.69B | $1.83B |
| Total liabilities | $3.82B | $2.56B | $1.10B | $398.92M |
| Shareholders' equity | $3.12B | $1.04B | $1.58B | $1.43B |
| Return on year-end equity | -29.0% | -49.5% | 8.1% | 12.4% |
| Shares outstanding | n/a | n/a | 59.42M | 39.23M |
Revenue, most recent five fiscal years
| Fiscal year | Teleflex Inc | Integra Lifesciences Holdings Corp | Merit Medical Systems Inc | Penumbra Inc |
|---|---|---|---|---|
| Latest | $1.99B Ended 2025-12-31 | $1.64B Ended 2025-12-31 | $1.52B Ended 2025-12-31 | $1.40B Ended 2025-12-31 |
| 1 year earlier | $1.70B Ended 2024-12-31 | $1.61B Ended 2024-12-31 | $1.36B Ended 2024-12-31 | $1.19B Ended 2024-12-31 |
| 2 years earlier | $1.71B Ended 2023-12-31 | $1.54B Ended 2023-12-31 | $1.26B Ended 2023-12-31 | $1.06B Ended 2023-12-31 |
| 3 years earlier | $2.79B Ended 2022-12-31 | $1.56B Ended 2022-12-31 | $1.15B Ended 2022-12-31 | $847.13M Ended 2022-12-31 |
| 4 years earlier | $2.81B Ended 2021-12-31 | $1.54B Ended 2021-12-31 | $1.07B Ended 2021-12-31 | $747.59M Ended 2021-12-31 |